← All Sponsors
SPONSOR

Shandong New Time Pharmaceutical Co., LTD

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Relapsed or Refractory Multiple Myeloma
NCT07312188 Phase 2
Recruiting

A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma
China View Trial →